Detalles de la búsqueda
1.
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Br J Haematol
; 158(6): 749-62, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22844968
2.
Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies.
Br J Haematol
; 154(4): 448-56, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21770918
3.
Epidemiology and management of lymphoma in low-income countries.
Hematol Oncol
; 29(1): 1-4, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21381073
4.
Efficacy of an intensive post-induction chemotherapy regimen for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia, given predominantly in the out-patient setting.
Ann Hematol
; 90(9): 1059-65, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21713399
5.
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia.
Br J Haematol
; 151(4): 346-53, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880120
6.
Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management.
Haematologica
; 95(7): 1130-5, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20107155
7.
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
Br J Haematol
; 145(6): 733-40, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19344416
8.
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up.
Br J Haematol
; 167(5): 724-6, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25074579
9.
Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence.
Oncologist
; 14 Suppl 2: 17-29, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19819921
10.
Primary follicular lymphoma of the testis and epididymis in adults.
Am J Surg Pathol
; 31(7): 1050-8, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17592272
11.
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
J Clin Oncol
; 21(12): 2335-41, 2003 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12805335
12.
The clinical course of follicular lymphoma.
Best Pract Res Clin Haematol
; 18(1): 1-10, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15694181
13.
Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy.
Br J Haematol
; 147(3): 408-10, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19664002
14.
High-dose treatment with autologous haemopoietic progenitor cell support for large B-cell, follicular and mantle-cell lymphoma.
Best Pract Res Clin Haematol
; 15(3): 467-80, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12468400
15.
Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.
Hematol J
; 3(5): 237-43, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12391541
16.
Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: an appraisal in elderly patients with acute myelogenous leukemia.
Hematol J
; 3(6): 290-8, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12522451
17.
90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.
J Clin Oncol
; 31(16): 1977-83, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23547079
18.
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.
J Clin Oncol
; 31(5): 573-83, 2013 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23295790
19.
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
J Clin Oncol
; 29(31): 4096-104, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21969511
20.
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.
J Clin Oncol
; 28(12): 2085-93, 2010 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20308665